Mahzad Erami Hossein Mirhendi Mansooreh Momen-Heravi Seyed Jamal Hashemi Hezaveh Amir Hossein Ahsaniarani Seddighe Sadat Sabet Shima Aboutalebian
10.3389/fcimb.2022.898477
Front Cell Infect Microbiol
2022 Oct 14;12:898477.
covid-19 antifungal susceptibility testing apophysomyces variabilis immunocompetent patient invasive fungal infection mucormycosis
CC BY
https://pubmed.ncbi.nlm.nih.gov/36310874/
COVID-19 / complications Mucorales / genetics Mucormycosis / complications Mucormycosis / diagnosis Mucormycosis / drug therapy
COVID-19 / complications Mucorales / genetics Mucormycosis / complications Mucormycosis / diagnosis Mucormycosis / drug therapy Review Case Reports Research Support, Non-U.S. Gov't Adult Antifungal Agents / therapeutic use Female Humans SARS-CoV-2 Antifungal Agents Apophysomyces variabilis
PMC9615570
36310874
A case of COVID-19-associated rhino-orbito-cerebral mucormycosis caused by Apophysomyces variabilis with a review of the literature
2022